Skip to main content
Top

International Journal of Clinical Oncology

Issue 2/2008

Content (20 Articles)

Introduction to Review Articles

Cancer registration system: an introduction

Tomotaka Sobue

Review Article

The role of cancer registries in cancer control

Donald Maxwell Parkin

From the Asco-Jsco Joint Symposium

Current status of chemoradiotherapy for gastric cancer in Japan

Toshimasa Tsujinaka, Kazumasa Fujitani, Motohira Hirao, Yukimori Kurokawa

From the Asco-Jsco Joint Symposium

Chemoradiotherapy for unresectable pancreatic cancer

Edgar Ben-Josef, Theodore S. Lawrence

From the Asco-Jsco Joint Symposium

Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan

Takuji Okusaka, Yoshinori Ito, Junji Furuse, Shigeru Yamada, Hiroshi Ishii, Keiko Shibuya, Tatsuya Ioka, Hiroyuki Shinchi

Original Article

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

Yutaka Yonemura, Cheng-Chung Wu, Norimasa Fukushima, Ichirou Honda, Etsurou Bandou, Taiichi Kawamura, Tohru Kamata, Byung-Sik Kim, Nobuo Matsuki, Toshiharu Sawa, Sung-Hoon Noh

Original Article

5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil

Shigehiro Tsujimoto, Kiyohide Fujimoto, Eijiro Okajima, Seiichiro Ozono, Eigoro Okajima, Yoshihiko Hirao

Original Article

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer

Nozomu Fuse, Toshihiko Doi, Atsushi Ohtsu, Tomonori Yano, Yasuo Hamamoto, Keiko Minashi, Makoto Tahara, Manabu Muto, Masahiro Asaka, Shigeaki Yoshida

Original Article

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Hirofumi Yasui, Akira Fukutomi, Takayuki Yoshino, Yusuke Onozawa, Noriaki Hasuike, Tetsuya Inui, Yuichiro Yamaguchi, Hiroyuki Ono

Case Report

Small cell carcinoma of the ovary: clinical and biological study

Seiji Isonishi, Hiroshi Nishii, Motoaki Saitou, Makoto Yasuda, Takako Kiyokawa, Masaharu Fukunaga, Hiroshi Ishikawa, Tadao Tanaka

Case Report

Cavernous hemangioma mimicking a cystic renal cell carcinoma

Ei-Ichiro Takaoka, Noritoshi Sekido, Makito Naoi, Kiyoshi Matsueda, Koji Kawai, Toru Shimazui, Hideyuki Akaza

Case Report

Small cell carcinoma of the prostate treated with amrubicin

Manabu Katou, Norihito Soga, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura

Case Report

A malignant solitary fibrous tumor in the retroperitoneum

Hideaki Ito, Mamoru Fukuda, Yoshiaki Imamura, Haruki Fuse

Case Report

Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer

Satoshi Hashino, Sumiko Kobayashi, Mutsumi Takahata, Masahiro Onozawa, Masao Nakagawa, Takahito Kawamura, Fumie Fujisawa, Koh Izumiyama, Kaoru Kahata, Takeshi Kondo, Masahiro Asaka

Case Report

Deeply eosinophilic cell variant of signet-ring type of gastric carcinoma: a diagnostic dilemma

Ruchika Gupta, Raman Arora, Prasenjit Das, Manoj Kumar Singh

Case Report

Efficacy of Nyoshinsan/TJ-67, a traditional herbal medicine, for menopausal symtoms following surgery and adjuvant chemotherapy for premenopausal breast cancer

Toshiaki Kogure, Katsuhiko Ito, Hiroko Sato, Tomoyuki Ito, Yuko Oku, Jun Horiguchi, Izumi Takeyoshi, Takeshi Tatsumi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine